KOSDAQ large cap
PharmaResearch
A company leveraging salmon-derived PDRN, running the Rejuran regenerative brand along with fillers and medical devices. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
214450.KQ Updated Jul 11, 2026 2 AI consumers
Annual return · 2026-07-10'21+23.3%'22+3.4%'23+37.6%'24+130.3%'25+98%YTD-32.5%
Money in ▸·
PharmaResearch
▸ Money out·
Financials & Segments
- Segments · Regenerative medicine (Rejuran) · Medical devices (fillers) · Cosmetics/others
Revenue from
No refined links yet.
Pays to
No refined links yet.